CRIS Current Research Information System

FIORINI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.625
AS - Asia 3.483
EU - Europa 3.060
SA - Sud America 267
AF - Africa 114
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.553
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.583
SG - Singapore 1.243
IT - Italia 1.083
CN - Cina 997
GB - Regno Unito 516
VN - Vietnam 409
HK - Hong Kong 344
SE - Svezia 322
DE - Germania 312
BR - Brasile 212
IN - India 154
RU - Federazione Russa 150
IE - Irlanda 134
KR - Corea 133
NL - Olanda 117
FR - Francia 106
UA - Ucraina 82
JO - Giordania 74
ZA - Sudafrica 58
JP - Giappone 55
FI - Finlandia 47
BG - Bulgaria 40
EE - Estonia 36
ID - Indonesia 24
CA - Canada 23
AR - Argentina 20
AT - Austria 20
CI - Costa d'Avorio 20
ES - Italia 18
BE - Belgio 17
CH - Svizzera 17
MX - Messico 14
EC - Ecuador 13
SC - Seychelles 13
PY - Paraguay 10
BD - Bangladesh 7
IQ - Iraq 7
PL - Polonia 7
GR - Grecia 6
MY - Malesia 6
TG - Togo 6
CO - Colombia 5
EG - Egitto 5
RO - Romania 5
TR - Turchia 5
AL - Albania 4
CZ - Repubblica Ceca 4
HR - Croazia 4
LK - Sri Lanka 4
MA - Marocco 4
AU - Australia 3
DO - Repubblica Dominicana 3
LB - Libano 3
LT - Lituania 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
DZ - Algeria 1
ET - Etiopia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MT - Malta 1
NG - Nigeria 1
PH - Filippine 1
QA - Qatar 1
RE - Reunion 1
SI - Slovenia 1
SN - Senegal 1
TL - Timor Orientale 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.553
Salva come PNG Salva come JPEG
Città #
Singapore 814
Southend 455
Ashburn 401
Hong Kong 341
Hefei 327
Chandler 306
Fairfield 277
Santa Clara 257
Woodbridge 151
Princeton 144
Dublin 134
Seoul 132
Bologna 129
Wilmington 129
Dong Ket 125
Houston 119
Boardman 117
Beijing 115
Seattle 114
Cambridge 104
Milan 102
Ann Arbor 101
Amman 74
Rome 66
Los Angeles 64
Ho Chi Minh City 62
Hanoi 58
Westminster 52
Buffalo 46
Padova 45
Jacksonville 44
Nanjing 44
Berlin 43
New York 42
Tokyo 41
Redmond 40
Sofia 40
Jinan 37
Turin 35
Helsinki 32
Tappahannock 31
Redondo Beach 30
Bengaluru 29
Dallas 27
São Paulo 25
Parma 22
Shenyang 22
Abidjan 20
Des Moines 19
Changsha 18
San Diego 18
Guangzhou 17
Munich 17
Yubileyny 17
Brussels 16
Hebei 16
Nuremberg 16
Saint Petersburg 16
Jakarta 15
Naples 15
Bari 14
Mülheim 14
Shanghai 14
Zhengzhou 14
Florence 13
Nanchang 13
Tianjin 13
Verona 13
Council Bluffs 12
Dearborn 12
Moscow 12
Biên Hòa 11
Frattamaggiore 11
Lappeenranta 11
Nakano 11
Rovigo 11
Amsterdam 10
Johannesburg 10
Norwalk 10
Frankfurt am Main 9
London 9
Brescia 8
Brooklyn 8
Bühl 8
Catania 8
Chicago 8
Curitiba 8
Falkenstein 8
Hangzhou 8
Hải Dương 8
Modena 8
Phoenix 8
Shenzhen 8
Tongling 8
Vienna 8
Belo Horizonte 7
Bern 7
Faenza 7
Mexico City 7
Offida 7
Totale 6.559
Salva come PNG Salva come JPEG
Nome #
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 509
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 340
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 249
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 207
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 174
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 166
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 163
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 161
Gastroesophageal Reflux Disease and Barrett’s Esophagus 159
Black Garlic and Pomegranate Standardized Extracts for Blood Pressure Improvement: A Non-Randomized Diet-Controlled Study. 156
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 156
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 154
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 153
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 149
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 149
Therapy for H. pylori: Current concepts 147
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 146
In vivo dissolution of levothyroxine soft gel capsules 145
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 138
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 133
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 133
Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? 131
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 130
Diagnosi dell'infezione da Helicobacter pylori 129
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 124
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 122
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 121
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 121
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 120
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 119
Probiotici ricombinanti e loro potenziale sulla salute umana 117
Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study 117
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 116
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 114
Recombinant probiotics and their potential in human health 114
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 114
Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT 112
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 111
High eradication rate with sequential therapy in naïve Helicobacter pylori patients with multi-resistant strains 111
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 110
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 108
Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori 107
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 106
Rescue therapies for H. pylori infection in foreign patients treated in Italy. 105
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 104
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 103
Infezione da Helicobacter pylori e nuovi orientamenti terapeutici: la terapia sequenziale 102
Nephrotic Range Proteinuria and Acute Heart Failure 101
Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019 100
Serum uric acid to eGFR ratio correlates with adverse outcomes in elderly hospitalized for acute heart failure 98
Morfologia e modalità di adesione all’epitelio dell’ileo terminale dei batteri filamentosi segmentati. Effetti sulla relazione con il sistema immunitario 98
Pylera and sequential therapy for first-line Helicobacter pylori eradication: A culture-based study in real clinical practice 97
Diagnostic yield of upper endoscopy according to appropriateness: A systematic review 96
Severe impaired blood pressure control caused by baroreflex failure as a late sequela of neck irradiation 95
Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management 94
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels 94
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale 94
Comparison of the management of Helicobacter pylori infection between the older and younger European populations 93
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review 93
Role of Helicobacter Pylori Infection in the Thyroid Diseases 88
More Than 90% Eradication Rate With Sequential Therapy in Clarithromycin Resistant Helicobacter pylori Patients: A Prospective Uncontrolled Study 87
Efficacy of a new nutraceutical formulation (CHETOGERD®) in patients with nonerosive reflux (NERD): a prospective observational study. 87
Upper Endoscopy in Patients with Extra-Oesophageal Reflux Symptoms: A Multicentre Study 86
The role of the occupational physician in controlling gastric cancer attributable to Helicobacter pylori infection: A review 86
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection 84
null 83
Whipple’s Disease: Case Report and Review of the Literature 83
Sequential therapy for first-line helicobacter pylori eradication: 10- or 14-day regimen? 82
null 81
European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients 78
Efficacy and Safety of Low-Dose Bisoprolol/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Systematic Review and Meta-Analysis 77
Helicobacter pylori: la nuova terapia. 77
Paradigm shift: The copernican revolution in diverticular disease 76
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 75
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg) 74
Statin therapy may protect against acute kidney injury in patients hospitalized for interstitial SARS-CoV2 pneumonia. 69
Newer agents for Helicobacter pylori eradication 68
Gestione del paziente, diagnostica rapida, nuove terapie per l’infezione da Helicobacter pylori. 67
Rescue Therapies for Helicobacter pylori Infection in Foreign Patients Treated in Italy 67
Clinical Performance of the Automated LIAISON® Meridian H. pylori SA Stool Antigen Test 64
Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review 64
null 62
Rescue Therapies for H. pylori Infection in Italy 62
Effectiveness of high-dose esomeprazole or pantoprazole 10-day sequential therapy empirically prescribed in Helicobacter pylori-infected naïve patients: a retrospective study 60
Gout, urate-lowering drugs, and risk of cardiovascular disease: can we clinically trust in the adjusted real-life data? 60
Lung ultrasound in the COVID-19 era: a lesson to be learned for the future 59
Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains 56
Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study 55
Helicobacter Pylori infection in psoriatic patients during biological therapy 54
Effect of dietary supplementation with Diuripres® on blood pressure, vascular health, and metabolic parameters in individuals with high-normal blood pressure or stage I hypertension: The CONDOR randomized clinical study 54
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 49
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 49
Is the First Cut Always the Deepest? 49
Diverticulosis, Adenomas, and Cancer in the Colon A Systematic Review and Meta-Analysis of Endoscopic Studies 46
First-line therapies for H. pylori infection in Italy: a pooled-data analysis 45
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 44
A new non-invasive tool for guiding H. pylori treatment. 43
New strategies for the treatment of hyperkalemia. 37
Cancer Prevention at Work (CPW) project: Rationale, framework and research protocol 31
Comparative Evaluation of Tongue and Periodontal Pocket Microbiome in Relation to Helicobacter pylori Gastric Disease: 16S rRNA Gene Sequencing Analysis 28
Totale 10.674
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021435 0 0 0 0 0 21 24 36 65 37 29 223
2021/20221.194 114 40 58 123 125 44 27 86 42 31 333 171
2022/20231.375 118 140 89 160 77 110 55 92 314 70 93 57
2023/2024719 45 123 49 83 39 96 39 40 23 65 66 51
2024/20252.432 107 356 194 169 392 145 161 95 50 102 143 518
2025/20262.717 413 513 461 432 585 313 0 0 0 0 0 0
Totale 10.781